← All articles Emerging Substances

Nitazenes: A New Wave of Synthetic Opioids in the Drug Supply

As awareness of fentanyl has grown, a new class of synthetic opioids has been quietly spreading through the U.S. drug supply. They are called nitazenes — a group of benzimidazole-opioid compounds that were first developed as potential pain medications in the 1950s but were never approved for medical use anywhere in the world. Today they are showing up in street drugs, counterfeit pills, and toxicology reports, and federal agencies are sounding the alarm.

What are nitazenes?

Nitazenes are man-made opioids — not derived from the poppy plant, not related to fentanyl chemically, but acting on the same brain receptors. Because they belong to a different chemical family than fentanyl, they can be synthesized when fentanyl supply chains are disrupted, and standard drug tests do not detect most of them.

There are many different nitazene compounds, and their potency varies widely. According to the U.S. Drug Enforcement Administration's Diversion Control Division, nitazenes as a group "can match or surpass the potency of fentanyl." Some of the most dangerous analogs — including isotonitazene, protonitazene, and etonitazene — have been found to be five to eight times more potent than fentanyl. Others, like metonitazene and butonitazene, are similar in strength to fentanyl or weaker. Because the average person using street drugs has no way to know which variant is present, every exposure carries an unpredictable overdose risk.

Where are nitazenes showing up?

Lab data and law enforcement seizures show that nitazenes are increasingly being found mixed into existing drug supplies — often without users' knowledge. The DEA's 2025 National Drug Threat Assessment warns that nitazenes are "now being encountered with growing frequency, often disguised in counterfeit pills or mixed into other narcotics" including fentanyl, heroin, and cocaine. Between 2023 and 2024, laboratory data showed a 17 percent rise in nitazene detections among fentanyl-positive drug samples. As of the DEA's most recent reporting, nitazenes have been detected in at least 15 states, with Florida alone recording more than 200 confirmed exhibits.

A December 2024 CDC Morbidity and Mortality Weekly Report (MMWR) on drug overdose deaths noted that nitazene analogs are "currently rare but persistent in overdose deaths" and called for "rigorous monitoring" of these substances. Early mortality data from Tennessee — one of the first states to track nitazenes closely — documented a rapid rise from zero recorded nitazene deaths in 2019 to 42 in 2021, illustrating how quickly an emerging substance can spread.

Why are they especially dangerous?

Does naloxone (Narcan) work on nitazenes?

Yes — naloxone does reverse nitazene overdoses, and it should always be given if an opioid overdose is suspected. However, because some nitazenes bind tightly to opioid receptors and may have a longer duration of effect than heroin, multiple doses of naloxone may be needed. Research from NIDA shows that naloxone is effective against isotonitazene, metonitazene, and related compounds, but that repeated administration is often required to achieve full reversal.

This means that bystanders should not assume one dose of Narcan is enough if the person does not respond. Give a second dose after two to three minutes, call 911 immediately, and stay with the person — the overdose can return after naloxone wears off (typically within 30–90 minutes). Carrying at least two doses of naloxone is always wise; in an era of increasingly potent synthetic opioids, having more on hand could be the difference between life and death.

What can communities do?

How to find help

If you or someone you know is struggling with opioid use, help is available. Medications like buprenorphine (Suboxone) and methadone are proven-effective treatments for opioid use disorder and are now more accessible than ever — many providers can prescribe buprenorphine via telehealth. SAMHSA's National Helpline connects callers to free, confidential treatment referrals 24 hours a day, 7 days a week.

If you need help right now: Call or text 988 (Suicide & Crisis Lifeline, which also assists with substance use crises), or call SAMHSA's free, confidential National Helpline at 1-800-662-4357 (1-800-662-HELP) — available 24/7, in English and Spanish, at no cost. In a medical emergency, call 911.

Sources

  1. DEA Diversion Control Division, "Nitazenes." deadiversion.usdoj.gov/drug_chem_info/nitazenes/nitazenes.html
  2. DEA, 2025 National Drug Threat Assessment. dea.gov/documents/2025/2025-05/2025-05-13/national-drug-threat-assessment
  3. CDC MMWR, "Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021." cdc.gov/mmwr/volumes/71/wr/mm7137a5.htm
  4. CDC MMWR, "Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024" (Dec. 2024). cdc.gov/mmwr/volumes/73/wr/mm7348a2.htm
  5. NIDA, "Emerging Drug Trends." nida.nih.gov/research-topics/emerging-drug-trends
  6. Gatch MB & Forster MJ, "Nitazenes: An Old Drug Class Causing New Problems," PMC (2025). pmc.ncbi.nlm.nih.gov/articles/PMC12331301/
  7. DEA Public Safety Advisory (May 12, 2026). dea.gov/press-releases/2026/05/12/public-safety-advisory
  8. SAMHSA National Helpline. samhsa.gov/find-help/national-helpline

This article is educational and is not a substitute for professional medical advice, diagnosis, or treatment. In an emergency, always call 911. For naloxone, always follow the instructions included with your specific product.